{"title":"药物警戒-药物安全监测工具","authors":"Shivangi Chauhan","doi":"10.53411/jpadr.2021.2.3.4","DOIUrl":null,"url":null,"abstract":"The objective of this narrative review is to converse about drug safety, global \npharmacological authorities and their responsibility, the process of adverse event \nreporting, and the main functions of pharmacovigilance. Pharmacovigilance is a science \nthat ensures patient safety against both newly launched and well-established medicinal \nproducts in the market. Pharmacovigilance is considered a specific tool used for observing \nand estimating Adverse Drug Reactions (ADRs) and is essential for successful drug \nmanagement programs, clinical trials, and public health programs. In the few past years, \nthe number of reported ADRs got increased as a result of which the volume of data got \nincreased. To handle such huge data and the need to understand the pharmacovigilance, it \nrequires highly skilled and proficient people for immediate detection of drug's side effects \nand protects the product from improper removal. The existing global network of \npharmacovigilance centers will be strengthened through an independent review process in \ncoordination with the Uppsala Monitoring Center. Its main role is to assess trials and \ncrucial issues of drug safety that probably influence public health beyond national \nborders. In this global arena, Pharmacovigilance becomes an important and integral part \nof clinical research. Most of the countries set up pharmacovigilance centers to monitor \ndrug safety; however, millennial pharmacovigilance faces major challenges for improved \nsafety and drug monitoring. \n ","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Pharmacovigilance- A drug safety monitoring tool\",\"authors\":\"Shivangi Chauhan\",\"doi\":\"10.53411/jpadr.2021.2.3.4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The objective of this narrative review is to converse about drug safety, global \\npharmacological authorities and their responsibility, the process of adverse event \\nreporting, and the main functions of pharmacovigilance. Pharmacovigilance is a science \\nthat ensures patient safety against both newly launched and well-established medicinal \\nproducts in the market. Pharmacovigilance is considered a specific tool used for observing \\nand estimating Adverse Drug Reactions (ADRs) and is essential for successful drug \\nmanagement programs, clinical trials, and public health programs. In the few past years, \\nthe number of reported ADRs got increased as a result of which the volume of data got \\nincreased. To handle such huge data and the need to understand the pharmacovigilance, it \\nrequires highly skilled and proficient people for immediate detection of drug's side effects \\nand protects the product from improper removal. The existing global network of \\npharmacovigilance centers will be strengthened through an independent review process in \\ncoordination with the Uppsala Monitoring Center. Its main role is to assess trials and \\ncrucial issues of drug safety that probably influence public health beyond national \\nborders. In this global arena, Pharmacovigilance becomes an important and integral part \\nof clinical research. Most of the countries set up pharmacovigilance centers to monitor \\ndrug safety; however, millennial pharmacovigilance faces major challenges for improved \\nsafety and drug monitoring. \\n \",\"PeriodicalId\":388338,\"journal\":{\"name\":\"Journal of Pharmacovigilance and Drug Research\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacovigilance and Drug Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53411/jpadr.2021.2.3.4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacovigilance and Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53411/jpadr.2021.2.3.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The objective of this narrative review is to converse about drug safety, global
pharmacological authorities and their responsibility, the process of adverse event
reporting, and the main functions of pharmacovigilance. Pharmacovigilance is a science
that ensures patient safety against both newly launched and well-established medicinal
products in the market. Pharmacovigilance is considered a specific tool used for observing
and estimating Adverse Drug Reactions (ADRs) and is essential for successful drug
management programs, clinical trials, and public health programs. In the few past years,
the number of reported ADRs got increased as a result of which the volume of data got
increased. To handle such huge data and the need to understand the pharmacovigilance, it
requires highly skilled and proficient people for immediate detection of drug's side effects
and protects the product from improper removal. The existing global network of
pharmacovigilance centers will be strengthened through an independent review process in
coordination with the Uppsala Monitoring Center. Its main role is to assess trials and
crucial issues of drug safety that probably influence public health beyond national
borders. In this global arena, Pharmacovigilance becomes an important and integral part
of clinical research. Most of the countries set up pharmacovigilance centers to monitor
drug safety; however, millennial pharmacovigilance faces major challenges for improved
safety and drug monitoring.